Atlas Trials

Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer

Clinical trial NCT02283372 · COMPLETED

Trial details

NCT number
NCT02283372
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2015-01-21
Primary completion
2018-05-14
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.